<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0235958.ref008">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Wensing</surname>
   <given-names>AMJ</given-names>
  </name>, 
  <name>
   <surname>van de Vijver</surname>
   <given-names>DA</given-names>
  </name>, 
  <name>
   <surname>Angarano</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Asjö</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Balotta</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Boeri</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management</article-title>. 
  <source>J Infect Dis</source>. 
  <year>2005</year>
  <month>9</month>
  <day>15</day>; 
  <volume>192</volume>(
  <issue>6</issue>):
  <fpage>958</fpage>–
  <lpage>66</lpage>. 
  <pub-id pub-id-type="doi">10.1086/432916</pub-id>
  <?supplied-pmid 16107947?>
  <pub-id pub-id-type="pmid">16107947</pub-id>
 </mixed-citation>
</ref>
